Amicus Therapeutics

Patent cliffs & loss of exclusivity

Amicus Therapuetics is a biotechnology company developing therapies to cure rare diseases.

Company

AngelList URLhttps://angel.co/amicus-therapeutics
Apple App Store URLhttps://apps.apple.com/gb/app/amicus-assist-myday/id1436305956
CAGE Code603U6
Legal NameAmicus Therapeutics, Inc.
Company Operating StatusAcquired
Crunchbase URLhttps://www.crunchbase.com/organization/amicus-therapeutics
Facebook URLhttps://www.facebook.com/pages/Amicus-Therapeutics/357833324290284
Full AddressOne Globeside Fieldhouse Lane Marlow SL7 1HZ United Kingdom

2 upcoming patent cliffs

DrugIngredientTypeCliff
  1. OPFOLDAMIGLUSTATSmall mol.Sep 2038
  2. GALAFOLDMIGALASTAT HYDROCHLORIDESmall mol.Jan 2042
  3. Pombiliticipaglucosidase alfa-atgaBiologic—

Loss-of-exclusivity dates are derived from the FDA Orange & Purple Books; company detail is from the CliffBio graph. Estimates are projections, not legal advice.